Stock News

Streaming Pioneer Roku Launches UK Channel, Shares Soar 10%

Roku, Inc. (ROKU) has announced the arrival of “The Roku Channel” in the UK, a streaming channel providing consumers with free access to …

GlaxoSmithKline, Vir Biotech Team Up in Hunt For Coronavirus Treatment 

British drugmaker GlaxoSmithKline (GSK) and Vir Biotechnology Inc (VIR) on Monday announced a partnership to develop potential antibody treatments for COVID-19, the disease …

Michael Kors, Versace Parent Furloughs U.S. Workers, Suspends Share Buyback

Capri Holdings Ltd. (CPRI) on Wednesday announced that it would furlough all of its 7,000 employees in North America and suspend share buybacks …

Gilead Sciences, Second Genome in Pact For Inflammatory Disease Drug Finds

Gilead Sciences Inc. (GILD) and Second Genome have entered into a four-year partnership aimed at joining forces in biomarker research and discovery of …

British American Tobacco Unit to Develop Tobacco-Based Coronavirus Drug

British American Tobacco (BTI)  has said that its U.S.

Tenneco Soars 16% in Pre-Market Trading On Carl Icahn Stake Disclosure

Shares of Tenneco (TEN), a manufacturer of automotive products and solutions, are spiking over 16% in Monday’s pre-market trading. The move comes after …

“Our Bank Cannot be Immune”, Says JP Morgan’s Jamie Dimon In Annual Shareholder Letter

JP Morgan’s (JPM) CEO and Chairman, Jamie Dimon, has today released his annual shareholder letter, in which he sets out how the company …

RedHill Biopharma Says First Coronavirus Patient Treated With Opaganib Drug

RedHill Biopharma Ltd. (RDHL) said on Monday that its first coronavirus patient has been treated with with the company’s new proprietary drug called …

Broadcom Dividend Is Safe Says Top Analyst, CFO Notes Recovery in Chinese Demand

Broadcom’s (AVGO) group-high dividend yield is safe from coronavirus-related pressures, says Oppenheimer analyst Rick Schafer after speaking to Broadcom CFO Tom Krause. “Balance sheet remains …

Acceleron Receives Thumbs Up From Street On FDA Reblozyl Label Expansion

Acceleron (XLRN) has received U.S.

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts